The sad truth is that, if everyone on the Forbes 400 list simultaneously (and tragically) got Cancer, or Parkinsons (or any given disease for that matter), the world would probably be well on its way to finding a cure for these illnesses, thanks to the enormous wealth that would be incentivized to back those efforts. Continue Reading →